Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …

Background Non-alcoholic fatty liver disease (NAFLD) is an emerging disease and a
leading cause of chronic liver disease. The prevalence in the general population is …

Introduction We characterized the association of 3 metabolic conditions–obesity, metabolic
syndrome, and nonalcoholic fatty liver disease (NAFLD)–with increased inflammation and …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease.
NAFLD includes a wide spectrum of liver conditions ranging from simple steatosis to …

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of
atherosclerotic cardiovascular disease. In our meta‐analysis, we aimed to assess the …

Objective—The goal of this study was to assess the independent and collective associations
of hepatic steatosis, obesity, and the metabolic syndrome with elevated high-sensitivity C …

Background Non-alcoholic fatty liver disease (NAFLD) is a well-established risk factor for
cardiovascular disease, with ethnic and regional differences noted. With the recent surge of …

Non-alcoholic fatty liver disease (NAFLD) refers to fatty infiltration of liver in the absence of
significant alcohol intake, use of steatogenic medication, or hereditary disorders. It is a …

Opportunistic screening at chest computed tomography: literature review of cardiovascular
significance of incidental findings - PMC Back to Top Skip to main content NIH NLM Logo …

Visceral abdominal fat has been associated to cardiovascular risk factors and coronary
artery disease (CAD). Computed tomography (CT) coronary angiography is an emerging …